BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25217643)

  • 21. The SCF
    Lou Y; Han M; Song Y; Zhong J; Zhang W; Chen YH; Wang H
    J Immunol; 2020 Apr; 204(8):2122-2132. PubMed ID: 32188758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin, bone regulation and the ubiquitin-proteasome connection: A review.
    Vriend J; Reiter RJ
    Life Sci; 2016 Jan; 145():152-60. PubMed ID: 26706287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA damage regulates UHRF1 stability via the SCF(β-TrCP) E3 ligase.
    Chen H; Ma H; Inuzuka H; Diao J; Lan F; Shi YG; Wei W; Shi Y
    Mol Cell Biol; 2013 Mar; 33(6):1139-48. PubMed ID: 23297342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RIPK4 activity in keratinocytes is controlled by the SCF
    Tanghe G; Urwyler-Rösselet C; De Groote P; Dejardin E; De Bock PJ; Gevaert K; Vandenabeele P; Declercq W
    Cell Mol Life Sci; 2018 Aug; 75(15):2827-2841. PubMed ID: 29435596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase.
    Li Y; Kumar KG; Tang W; Spiegelman VS; Fuchs SY
    Mol Cell Biol; 2004 May; 24(9):4038-48. PubMed ID: 15082796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2.
    Donninger H; Calvisi DF; Barnoud T; Clark J; Schmidt ML; Vos MD; Clark GJ
    J Cell Biol; 2015 Mar; 208(6):777-89. PubMed ID: 25778922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The characteristics and roles of β-TrCP1/2 in carcinogenesis.
    Bi Y; Cui D; Xiong X; Zhao Y
    FEBS J; 2021 Jun; 288(11):3351-3374. PubMed ID: 33021036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NORE1A directs apoptotic switch of TNF signaling through reciprocal modulation of ITCH-mediated destruction of TNFRI and BAX.
    Ko KP; Jeong SI; Lim JS; Lee KW; Lee MG; Chi SG
    Oncogene; 2020 Aug; 39(34):5675-5689. PubMed ID: 32690868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover.
    Hong X; Nguyen HT; Chen Q; Zhang R; Hagman Z; Voorhoeve PM; Cohen SM
    EMBO J; 2014 Nov; 33(21):2447-57. PubMed ID: 25180228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation.
    Westbrook TF; Hu G; Ang XL; Mulligan P; Pavlova NN; Liang A; Leng Y; Maehr R; Shi Y; Harper JW; Elledge SJ
    Nature; 2008 Mar; 452(7185):370-4. PubMed ID: 18354483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DEPTOR ubiquitination and destruction by SCF(β-TrCP).
    Wang Z; Zhong J; Gao D; Inuzuka H; Liu P; Wei W
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E163-9. PubMed ID: 22454292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudosubstrate regulation of the SCF(beta-TrCP) ubiquitin ligase by hnRNP-U.
    Davis M; Hatzubai A; Andersen JS; Ben-Shushan E; Fisher GZ; Yaron A; Bauskin A; Mercurio F; Mann M; Ben-Neriah Y
    Genes Dev; 2002 Feb; 16(4):439-51. PubMed ID: 11850407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SCF
    Ci Y; Li X; Chen M; Zhong J; North BJ; Inuzuka H; He X; Li Y; Guo J; Dai X
    Protein Cell; 2018 Oct; 9(10):879-889. PubMed ID: 29497989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted polyubiquitylation of RASSF1C by the Mule and SCFβ-TrCP ligases in response to DNA damage.
    Zhou X; Li TT; Feng X; Hsiang E; Xiong Y; Guan KL; Lei QY
    Biochem J; 2012 Jan; 441(1):227-36. PubMed ID: 21910689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. H-Ras is degraded by Wnt/beta-catenin signaling via beta-TrCP-mediated polyubiquitylation.
    Kim SE; Yoon JY; Jeong WJ; Jeon SH; Park Y; Yoon JB; Park YN; Kim H; Choi KY
    J Cell Sci; 2009 Mar; 122(Pt 6):842-8. PubMed ID: 19240121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SCF(beta-TRCP) and phosphorylation dependent ubiquitinationof I kappa B alpha catalyzed by Ubc3 and Ubc4.
    Strack P; Caligiuri M; Pelletier M; Boisclair M; Theodoras A; Beer-Romero P; Glass S; Parsons T; Copeland RA; Auger KR; Benfield P; Brizuela L; Rolfe M
    Oncogene; 2000 Jul; 19(31):3529-36. PubMed ID: 10918611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure of the complex between phosphorylated substrates and the SCF beta-TrCP ubiquitin ligase receptor: a combined NMR, molecular modeling, and docking approach.
    Evrard-Todeschi N; Pons J; Gharbi-Benarous J; Bertho G; Benarous R; Girault JP
    J Chem Inf Model; 2008 Dec; 48(12):2350-61. PubMed ID: 19053519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ubiquitin-specific protease USP47 is a novel beta-TRCP interactor regulating cell survival.
    Peschiaroli A; Skaar JR; Pagano M; Melino G
    Oncogene; 2010 Mar; 29(9):1384-93. PubMed ID: 19966869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin.
    Latres E; Chiaur DS; Pagano M
    Oncogene; 1999 Jan; 18(4):849-54. PubMed ID: 10023660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ubiquitin ligase SCF(betaTrCP) regulates the degradation of the growth hormone receptor.
    van Kerkhof P; Putters J; Strous GJ
    J Biol Chem; 2007 Jul; 282(28):20475-83. PubMed ID: 17500058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.